Pharmacotherapy in Childhood Anemia

Article information

J Korean Med Assoc. 2007;50(2):170-174
Publication date (electronic) : 2007 February 28
doi : https://doi.org/10.5124/jkma.2007.50.2.170
Department of Pediatrics, College of Medicine, The Catholic University of Korea, Korea. dcjeong@catholic.ac.kr

Abstract

Anemia is one of the important causes compromising normal growth, development, and immune function in children. In outpatient clinics, we can see patients with anemia caused by various etiologies, whether congenital or acquired. Most cases of childhood anemia are caused by incomplete supplements of nutrients for erythropoiesis, despite the improved socioeconomic situation. Sometimes we need to treat the underlying diseases to correct the anemia. Also, we have to evaluate the etiology of anemia according to age, and consider medical treatments on the basis of the underlying causes. In this article, the author reviews pharmacotherapy in childhood anemia.

References

1. Moy RJD. Prevalence, consequences and prevention of childhood nutritional iron deficiency: a child public health perspective. Clin Lab Haem 2006. 28291–298.
2. The Korean Society of Hematology. In : Cha YJ, ed. Classification of anemia. Hematology 2006. 1st edth ed. Seoul: E-public; 44–46.
3. Bourke B, Ceponis P, Chiba N, Czinn S, Ferraro R, Woodland R, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents-an evidence-based evaluation. Can J Gastroenterol 2005. 19399–408.
4. The Korean Society of Pediatrics. In : Ahn HS, ed. Blood disorders. Pediatrics 2004. 8th edth ed. Seoul: Daehan Printing & Pubishing Co., Ltd; 813–817.
5. The Korean Society of Hematology. In : Cha YJ, ed. Disorder of iron metabolism. Hematology 2006. 1st edth ed. Seoul: E-public; 75–81.
6. Yun DJ, Lee H, Chun GP, Lee KY. Juvenile pernicious anemia in sisters. Yonsei Med J 1967. 871–76.
7. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res 2006. 4236–241.
8. The Korean Society of Hematology. In : Cha YJ, ed. Megaloblastic anemia. Hematology 2006. 1st edth ed. Seoul: E-public; 90–100.
9. Sackey K. Hemolytic anemia. Pediatr Rev 1999. 20152–158.
10. Kellermayer R, Faden H, Grossi M. Clinical presentation of parvovirus B19 infection in children with aplastic crisis. Pediatr Infect Dis J 2003. 221100–1101.
11. Park SJ, Yang WS, Hwang HS, Jang PS, Kim HH, Kim JH, Koh DK, Lee KY, Cho B, Jeong DC, Kim HK. Clinical Manifestations and Factors Associated with Complications and Splenectomy in Hereditary Spherocytosis. Clin Pediatr Hematol-Oncol 2006. 13158–166.
12. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Alberti D, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with-thalassmia. Blood 2006. 1073455–3462.
13. The korean Society of Hematology. In : Cha YJ, ed. Autoimmune hemolytic anemia. Hematology 2006. 1st edth ed. Seoul: E-public; 125–130.
14. Gottardo NG, Baker DL, Willis FR. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab. Pediatr Hematol Oncol 2003. 20557–561.
15. Di Raimondo F, Giustolisi R, Cacciola E, O'Brien S, Kantarjian H, Robertson LB, Keating MJ. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993. 1163–68.
16. Jeong DC, Kang IJ, Koo HH, Kook H, Kim SY, Hwang TJ, et al. Epidemiology and Clinical Outcomes in Children with Aplastic Anemia in Korea: Retrospective Study. Korean J Pediatr Hematol-Oncol 2004. 11137–152.
17. Young NS. Immunosuppressive treatment of acquired aplastic anemia and immne-mediated bone marrow failure syndrome. Int J Hematol 2002. 75129–140.
18. Young NS, Calado RT, Scheinberg P. Current concepts in pathophysiology and treatment of aplastic anemia. Blood 2006. 1082509–2519.
19. Marwaha RK, Bansal D, Trehan A, Marwaha N, Varma N. Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr 2002. 48113–116.

Article information Continued

Table 1

Iron preparation prescribed in clinics

Table 1